Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 19, 2022

SwanBio raises $56m to advance new gene therapies for neurological conditions

SwanBio Therapeutics, a gene therapy company, has raised $56m through Series B financing round to advance gene therapies for neurological conditions.

Continue
Image: With the proceeds from the latest funding round, the company plans to advance therapies for neurological conditions. Credit: Dmitriy Gutarev from Pixabay.
May 18, 2022

Procaps Group signs agreement to buy Grupo Somar

Grupo Somar develops, manufactures, and markets branded generic, private label and OTC products. Credit: Pexels from Pixabay.
May 17, 2022

Proteros expands oncology collaboration with AstraZeneca

Credit: This multi-year deal builds on the ongoing collaboration with AstraZeneca. Credit: Michal Jarmoluk from Pixabay

Contracts

May 3, 2022

Intravac signs licensing deal with Zhifei Lvzhu for whooping cough vaccine

Image: There are more than 24 million cases of whooping cough every year across the world. Credit: owfiqu barbhuiya on Unsplash.

Ardelyx amends license deal with Kyowa Kirin for tenapanor

Clovis Oncology, Evergreen partner for actinium-225-labeled FAP-2286

Altamira, Nuance Pharma sign distribution deal for Bentrio in Asian markets

Deals

Deals May 16, 2022

Statera Biopharma, Lay Sciences announce intent to enter strategic partnership

Pharmaceutical Business Review

Asahi Kasei Medical agrees to buy Bionova Scientific

Aurion Biotech raises $120m to advance cell therapy programme

ViGeneron signs gene therapy collaboration agreement with Regeneron Pharmaceuticals

Popular

  1. Stealth receives FDA orphan drug designation for elamipretide to treat DMD
  2. Artax Biopharma to develop oral small molecule immunomodulating agent
  3. Moma Therapeutics completes funding for precision oncology programmes
  4. GNS and Arvinas partner for neurodegenerative disease drug development
  5. InxMed raises funding to advance new cancer therapies

PRESS RELEASES

Pharmaceutical Business Review
Gerresheimer Boosts Global Production Capabilities with New State-of-the-Art Facilities in India
Pharmaceutical Business Review
Gerresheimer at Pharmapack: With the g guide, the Optimum Solution for Biotech and Pharma
Gerresheimer and Portal Enter Strategic Partnership to Treat Chronically Ill Patients with Innovative Needle-Free Drug-Delivery Solution
Gerresheimer and Portal Enter Strategic Partnership to Treat Chronically Ill Patients with Innovative Needle-Free Drug-Delivery Solution
New Recycled Wet Peel Product Launched Ahead of Plastic Packaging Tax
New Recycled Wet Peel Product Launched Ahead of Plastic Packaging Tax
Pharmaceutical Business Review
NETZSCH Future Days: 16–19 May 2022

Suppliers

Whitepapers

Deeper Insight into the Pyrolysis of Acetylsalicylic Acid by Means of Kinetic Analysis
Deeper Insight into the Pyrolysis of Acetylsalicylic Acid by Means of Kinetic Analysis
Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
Deuterium-Containing Building Blocks for Drug Design
Deuterium-Containing Building Blocks for Drug Design